OverviewChartTechnicalNewsTraderScreen

Mendus AB/  SE0005003654  /

OMX Nordic
2024-05-22  12:00:00 AM Chg. -0.010 Volume Bid5:29:31 PM Ask5:29:31 PM High Low
0.466SEK -2.00% 445,920
Turnover: 208,625.979		 0.461Bid Size: - 0.473Ask Size: - 0.479 0.459
GlobeNewswire 2019-04-25 Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019
GlobeNewswire 2019-04-25 Immunicum AB (publ) Interim Report January - March 2019
GlobeNewswire 2019-04-04 Immunicum AB (publ) Publishes the Annual Report for 2018
GlobeNewswire 2019-03-26 Notice of Annual General Meeting in Immunicum AB (publ)
GlobeNewswire 2019-03-22 Immunicum AB (publ) Announces Upcoming Conferences in March and April
GlobeNewswire 2019-02-15 Immunicum AB (publ) Year-End Report 2018
GlobeNewswire 2019-02-11 Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial
GlobeNewswire 2019-02-01 Immunicum AB (publ) Announces Upcoming Investor Events in February
GlobeNewswire 2019-01-31 Change in Number of Shares and Votes in Immunicum AB (publ) After Completed Rights Issue
GlobeNewswire 2019-01-30 Changes to the Nomination Committee for Immunicum AB (publ)
GlobeNewswire 2019-01-22 Immunicum AB (publ) Announces Upcoming Investor Events in January
GlobeNewswire 2019-01-21 Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Ad...
GlobeNewswire 2018-12-28 Change in Number of Shares and Votes in Immunicum AB (publ) After Completed Directed Issue
GlobeNewswire 2018-12-13 Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
GlobeNewswire 2018-11-23 Immunicum AB (publ) Publishes Prospectus in Connection with Rights Issue and Directed Issue
GlobeNewswire 2018-11-16 Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evalu...
GlobeNewswire 2018-11-08 Report from Extraordinary General Meeting of Immunicum AB (publ) on 8 November 2018
GlobeNewswire 2018-11-07 Immunicum AB (publ) Interim Report July - September 2018
GlobeNewswire 2018-10-24 Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm
GlobeNewswire 2018-10-22 Immunicum AB (publ) Announces Upcoming Investor Events in October and November
GlobeNewswire 2018-10-22 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhib...
GlobeNewswire 2018-10-19 Immunicum AB (publ) Announces Nomination Committee for AGM 2019
GlobeNewswire 2018-10-16 Immunicum AB (publ) Clarifies Information Regarding Directed Issue
GlobeNewswire 2018-10-16 Notice of Extraordinary General Meeting in Immunicum AB (publ)
GlobeNewswire 2018-10-16 Immunicum AB (publ) Raises SEK 351M in a Directed Issue and a Fully Guaranteed Rights Issue for Cont...